The Information Technology and Innovation Foundation noted ahead of the vote that adding these compounds to the 503A list could legitimize a Chinese gray-market supply chain one in which several chemical firms previously involved in illegal fentanyl precursor production have pivoted into peptide sales while allowing potentially dangerous compounds into American medicine
Things came up in my labs that, if they had only taken the time to research chronic Lyme, they would have known that was a factor
Regulatory Context: In the U.S., GHK-Cu injections can only be obtained via compounding pharmacies and physician prescriptions
That is an unpleasant property in an experiment and an intolerable one in a manufacturing process
Here's a little background info on it in case you're curious like me
Neri S, Pistone G, Saraceno B, Pennisi G, Luca S, Malaguarnera M: L-carnitine decreases severity and type of fatigue induced by interferon-alpha in the treatment of patients with hepatitis C